ARTFEED — Contemporary Art Intelligence

Ebola Treatment Trial Launches in Congo Amid Outbreak

other · 2026-07-05

Researchers in the Democratic Republic of Congo have begun a clinical trial of two experimental Ebola treatments in early July, targeting the Bundibugyo virus strain responsible for the current outbreak. The study, supported by the WHO and conducted at the Evangelical Medical Centre in Bunia, Ituri province, involves collaboration between the DRC's INRB, Oxford University, and the Institute of Tropical Medicine in Antwerp. Over 1,400 people have been diagnosed and 438 have died, according to WHO chief Tedros Adhanom Ghebreyesus. The trial offers hope as no specific treatments or vaccines exist for this strain.

Key facts

  • Experimental Ebola treatment trial began in early July 2025
  • Trial targets Bundibugyo virus strain
  • Location: Evangelical Medical Centre, Bunia, Ituri province, DRC
  • WHO-supported collaboration with INRB, Oxford University, Institute of Tropical Medicine in Antwerp
  • Over 1,400 diagnosed and 438 deaths reported
  • No specific treatments or vaccines for Bundibugyo strain
  • Trial involves two experimental treatments
  • WHO chief Tedros Adhanom Ghebreyesus announced death toll

Entities

Institutions

  • World Health Organization (WHO)
  • INRB (National Institute of Biomedical Research)
  • Oxford University
  • Institute of Tropical Medicine in Antwerp
  • Evangelical Medical Centre

Locations

  • Democratic Republic of Congo
  • DRC
  • Bunia
  • Ituri province
  • Congo

Sources